10x Genomics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-22.66	-43.54	-182.63	-255.1	-166	-58.22
Depreciation & Amortization	45.91	43.82	43.71	43.62	33.01	28.25
Stock-Based Compensation	100.68	109.12	140.75	166.95	136.85	95.96
Other Adjustments	-0.46	1.72	3.58	11.99	1.96	0.08
Change in Receivables	-2.78	6.44	26.95	-10.61	-18.95	-34.04
Changes in Inventories	22.6	27.95	-9.78	7.87	-21.19	-30.13
Changes in Accounts Payable	5.2	-2.13	-3.35	-6.02	5.86	11.08
Changes in Accrued Expenses	-17.8	2.49	-9.08	25.66	4.45	-28.71
Changes in Unearned Revenue	0.48	0.75	11.21	10.93	3.35	1.54
Changes in Other Operating Activities	-5.76	-10.57	-14.69	-10.49	-12.94	-7.18
Operating Cash Flow	127.82	136.05	6.66	-15.2	-33.61	-21.37
Operating Cash Flow Growth	125.27%	1941.57%	-	-	-	-
Capital Expenditures	-5.64	-5.94	-12.39	-48.6	-131.66	-101.28
Purchases of Intangible Assets	-	-	-1	-0.92	-	-
Purchases of Investments	-148.15	-123.44	-48.88	-	-282.87	-
Proceeds from Sale of Investments	150.2	125.2	29.64	183.02	67.65	-
Payments for Business Acquisitions	-0.65	-9.27	-	-	-4	-5.45
Investing Cash Flow	-12.86	-13.44	-32.63	133.49	-350.89	-106.73
Issuance of Common Stock	6.65	6.8	10.91	19.48	21.23	40.33
Net Common Stock Issued (Repurchased)	6.65	6.8	10.91	19.48	21.23	40.33
Other Financing Activities	-8.69	-	-	-5.81	-5.41	-5.03
Financing Cash Flow	-2.04	6.8	10.91	13.67	15.82	35.3
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.3	0.48	-0.16	-0.03	-0.04	0.23
Net Cash Flow	113.22	129.9	-15.22	131.93	-368.72	-92.57
Free Cash Flow	122.18	130.12	-5.73	-63.8	-165.27	-122.65
Free Cash Flow Growth	-6.10%	-	-	-	-	-
FCF Margin	19.13%	20.24%	-0.94%	-10.31%	-32.00%	-25.01%
Free Cash Flow Per Share	0.97	1.04	-0.05	-0.54	-1.45	-1.11
Levered Free Cash Flow	22.34	12.84	-177.01	-232.13	-285.12	-184.65
Unlevered Free Cash Flow	-0.56	-10.16	-194.34	-249.11	-291.25	-183.07

SEC Filings: 10-K · 10-Q